Gail Boudreaux - Nov 4, 2022 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
President and CEO, Director
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Nov 4, 2022
Transactions value $
$0
Form type
4
Date filed
11/4/2022, 05:05 PM
Previous filing
Mar 10, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Gift $0 -10K -8.24% $0.00 111K Nov 4, 2022 Direct F1
holding ELV Common Stock 60 Nov 4, 2022 Shares Held in Spouse's Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes 252.31 shares acquired on March 25, 2022, 257.62 shares acquired on June 24, 2022 and 266.45 shares acquired on September 23, 2022 through a dividend reinvestment plan.